This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Here's Why You Should Buy Innospec (IOSP) Stock Right Now
by Zacks Equity Research
Innospec (IOSP) shows strong growth potential, driven by its Oilfield Services unit, strategic acquisitions like QGP Quimica Geral and consistent earnings outperformance.
Innospec Inc. (IOSP) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Innospec (IOSP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Innospec's (IOSP) Stock Rallies 14% in 3 Months: Here's Why
by Zacks Equity Research
Innospec (IOSP) drives growth through strong earnings, strategic acquisitions like QGP in Brazil and investment in technology and capacity expansion amid optimism for 2024.
Are Basic Materials Stocks Lagging ICL Group (ICL) This Year?
by Zacks Equity Research
Here is how ICL Group (ICL) and Innospec (IOSP) have performed compared to their sector so far this year.
Innospec Inc. (IOSP) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Innospec (IOSP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Innospec's (IOSP) Earnings and Sales Surpass Estimates in Q4
by Zacks Equity Research
Innospec (IOSP) saw double-digit operating income growth and margin expansion across Performance Chemicals and Fuel Specialties units in Q4.
Innospec (IOSP) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Innospec (IOSP) delivered earnings and revenue surprises of 15.72% and 4.37%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Compass Minerals (CMP) Q1 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Compass (CMP) delivered earnings and revenue surprises of -79.17% and 7.21%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
LyondellBasell (LYB) Q4 Earnings and Revenues Miss Estimates
by Zacks Equity Research
LyondellBasell (LYB) delivered earnings and revenue surprises of -2.33% and 4.39%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Innospec's (IOSP) Stock Up 14% in 3 Months: Here's Why
by Zacks Equity Research
Innospec (IOSP) benefits from the strength in its Oilfield Services unit and strategic growth measures.
Innospec (IOSP) Expands Global Presence With QGP Acquisition
by Zacks Equity Research
Innospec (IOSP) achieves a strategic milestone with the acquisition of QGP Quimica Geral in Brazil, enhancing its global presence and strengthening the Performance Chemicals segment.
Innospec's (IOSP) Earnings Beat Estimates in Q3, Revenues Lag
by Zacks Equity Research
Innospec (IOSP) saw continued strong results in its Oilfield Services unit and a sequential improvement in the Performance Chemicals segment in Q3.
Mosaic (MOS) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Mosaic's (MOS) third-quarter results are likely to reflect favorable demand for phosphate and potash amid headwinds from weaker fertilizer prices.
Denison Mine (DNN) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Denison Mine's (DNN) third-quarter 2023 results are likely to reflect declines in toll milling revenues, higher general and administrative expenses, and exploration and evaluation costs.
Andersons (ANDE) to Report Q3 Earnings: Here's What to Expect
by Zacks Equity Research
Andersons' (ANDE) third-quarter 2023 results are likely to benefit from upbeat performances in all its segments.
Air Products (APD) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Air Products (APD) is expected to have gained from cost-improvement and productivity initiatives, higher volumes and pricing actions in Q4.
Celanese (CE) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Celanese (CE) is expected to have benefited from its cost actions and contributions of acquisitions amid demand headwinds in certain markets in Q3.
MP Materials (MP) to Report Q3 Earnings: Here's What to Expect
by Zacks Equity Research
MP Materials' (MP) third-quarter 2023 results are likely to reflect weak pricing and higher costs.
Innospec (IOSP) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Innospec (IOSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Energy Fuels (UUUU) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
Energy Fuels' (UUUU) third-quarter 2023 results are likely to reflect the sale of uranium per supply agreements with U.S. nuclear utilities. However, higher costs related to its expansion efforts are expected to hurt the margins.
Alpha Metallurgical (AMR) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
Alpha Metallurgical's (AMR) third quarter 2023 results are expected to reflect weaker-than-expected shipments and lower realized pricing.
LyondellBasell (LYB) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
LyondellBasell (LYB) delivered earnings and revenue surprises of 24.24% and 3.22%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Why Innospec (IOSP) Could Beat Earnings Estimates Again
by Zacks Equity Research
Innospec (IOSP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Methanex (MEOH) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Methanex (MEOH) delivered earnings and revenue surprises of 125% and 5.62%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Innospec's (IOSP) Earnings Beat Estimates in Q2, Revenues Lag
by Zacks Equity Research
Strong results in Innospec's (IOSP) Oilfield Services unit were partly offset by the weakness in the Performance Chemicals segment in Q2.